retatrutide clinical trials weight loss results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide is getting a lot
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 129.Juni RP, Kuster DWD, Goebel M, et al
Blue Crosss move is among the latest signs the surge in demand for GLP-1s, which doctors say provide broad health benefits to their patients, is pushing insurers and employers toward a financial breaking point
However, based on animal studies with GLP-1RA related peptide polyagonists, they seem to be more effective in improving hepatic fibrosis, possibly due to the additive or synergistic effects of more than one receptor agonist
The discovery of GLP-1R/GcgR dual agonists has provided a fresh medicinal approach and renewed hope that obesity and its associated abnormalities might be managed with medicines as opposed to surgical interventions
[DOI] [PubMed] [Google Scholar] 935.Norregaard P.K., Deryabina M.A., Tofteng Shelton P., Fog J.U., Daugaard J.R., Eriksson P.O
